A rejection by MHRA would be a material event and would have to be reported promptly so your characterization is misleading at best.
Before you (presumably) didn’t know about the backlog and had that fig leaf that the long delay did not make sense unless something was wrong with the application.
Now that you know about the backlog, unless you can show where Flipper was wrong, to imply that someone held up the process or is even teeing up a rejection in the UK is a scare tactic and arguing in bad faith by you.
You are the only one who has been misleading here.
It is fair to criticize NWBO pumpers for only discovering the MHRA backlog of applications months after talking up the 150 day process as at best it shows sloppy Due Diligence with rose-colored glasses and at worst they knew that the wait was not just 150 days plus RFI off clock time but chose not to tell the whole story.
There are bad actors on all sides and the retail shareholders are caught in the middle.
I just hope that NWBO does not F-up the MHRA approval announcement like prior pivotal news and this time is effective in amplifying it and getting our SP up to a level where at least those of who held our noses and have averaged down with what cash we could put together each payday are taken care of. As always, maybe this time is different.
Market Data 
Markets 
AI
